The best Bull and Bear pitches based on recency and number of recommendations.
Leader in immunotherapy research. Great long-term potential.
Advaxis has pulled off the surprising feat of not only recovering all the ground lost on the after hours plunge on Tuesday after announcement of the ADXS-HPV clinical hold, but they've actually gained ground from before the hold was announced. And… More
Read the most recent pitches from players about ADXS.
Recs
GorGecko99
(38.86)
Submitted: 5/22/2016 11:58:23 AM :
Start Price:
$118.80
NASDAQ:ADXS Score:
-204.25
Leader in immunotherapy research. Great long-term potential.
Recs
Beststocks99
(35.29)
Submitted: 5/22/2016 11:48:16 AM :
Start Price:
$118.80
NASDAQ:ADXS Score:
-204.25
Recent insider analyst said this stock has massive potential on upside.
Recs
biotechf
(56.51)
Submitted: 4/9/2015 7:00:31 AM :
Start Price:
$271.50
NASDAQ:ADXS Score:
-202.57
Immuotherapy cancer stock with recent announcement of positive clinical trial results in which all 10 patients showed a very good clinical outcome. It is still early in the clinical trial process but the ADXS has partnered with Big Pharma and in my opinion will receive an FDA breakthrough therapy designation soon. The company's market capitalization is small compared to its peers and I believe it will continue to catch up and reach $1 billion.
Find the members with the highest scoring picks in ADXS.
TheSlightEdge (99.17) Score: +447.64
The Score Leader is the player with the highest score across all their picks in ADXS.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| NobleOrSomeBull | 99.72 | 2/9/2016 |
|
5Y | $82.20 | -98.54% | +127.90% | +226.44 | 0 Comment | |
| MMCapitalMgmt | 99.96 | 8/21/2014 |
|
5Y | $45.30 | -97.35% | +111.33% | +208.68 | 0 Comment | |
| ziggystraw | 97.52 | 1/9/2015 |
|
5Y | $152.10 | -99.21% | +106.26% | +205.47 | 0 Comment | |
| Zencyclone | 31.32 | 3/16/2015 |
|
5Y | $210.75 | -99.43% | +103.05% | +202.48 | 0 Comment | |
| km00nster | < 20 | 6/9/2015 |
|
5Y | $401.25 | -99.70% | +102.36% | +202.06 | 0 Comment | |
| vaipalolo | 94.30 | 6/15/2015 |
|
1Y | $345.00 | -99.65% | +102.18% | +201.83 | 0 Comment | |
| Iwannabeadored | 26.45 | 4/20/2015 |
|
5Y | $279.75 | -99.57% | +101.77% | +201.34 | 0 Comment | |
| SimonSaysSell | 98.76 | 12/29/2014 |
|
NS | $134.52 | -99.11% | +102.06% | +201.17 | 0 Comment | |
| Clint35 | 72.10 | 5/1/2015 |
|
NS | $256.80 | -99.53% | +101.44% | +200.97 | 0 Comment | |
| OptimistPrime2 | 70.26 | 3/5/2015 |
|
5Y | $162.75 | -99.26% | +100.54% | +199.80 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
